Biotechnology Stocks II Performance Guide: Heron Therapeutics, Inc. (HRTX)
HRTX has no dividends.
Table and Chart of HRTX Performance
See what a $1,000 investment in HRTX is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| HRTX Returns | |
|---|---|
| Start Date | May-30-2014 |
| Start Price | $11.94 |
| End Date | May-16-2024 |
| End Price | $3.22 |
| # Prices | 121 |
| Min Date | Oct-31-2023 |
| Min Price | $0.64 |
| Max Date | Jun-29-2018 |
| Max Price | $38.85 |
| Total Return | -73.03% |
| Annualized Return | -12.19% |
| Current Value of $1,000 Purchase | $270 |
| Number Returns | 7,260 |
| Average Return | -19.78% |
| Number Profitable Returns | 2,190 |
| Percent Profitable Returns | 30.17% |
| Number Unprofitable Returns | 5,070 |
| Percent Unprofitable Returns | 69.83% |
| Profitable to Unprofitable Returns Ratio | 0.43 |
| HRTX Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $451,959,000 |
| Beta | 1.733 | Price to Sales | 3.44 |
| Earnings per Share | $-0.5500 |
| PE Ratio | None |
| PE to Growth Ratio | -0.18 |
| Price to Book | 12.6 |
| PRICE DATA | |
| 52 Week High | $3.23 |
| 52 Week Low | $0.5 |
| Analyst Target Price | $6.75 |
| 50-Day Moving Average | $2.749 |
| 200-Day Moving Average | $1.872 |
| FINANCIAL DATA | |
| Revenue per Share | $0.904 |
| Revenue | $132,099,000 |
| Profit Margin | -61.3% |
| Return on Equity | -2409% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
HRTX Compare Returns with S&P 500
HRTX Trendline Chart
HRTX Moving Average Chart
HRTX Stock Return Map - See Patterns of Gains and Losses
HRTX Stock Returns/Purchase Dates